Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuye Jiedu Granules is a Traditional Chinese Medicine (TCM) herbal formulation developed by the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine for the treatment of influenza. The preparation is designed to clear heat and detoxify, specifically targeting Wind-Heat syndromes associated with viral respiratory infections. Its primary active component is derived from *Pteris multifida* (羽叶凤尾草), which has demonstrated antiviral properties against various strains of the influenza virus and anti-inflammatory effects that help reduce fever and respiratory symptoms. It is typically administered as an oral granule and has been evaluated in clinical trials for its efficacy in reducing the duration and severity of influenza symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yuye jiedu granules.